| UniProt/SwissProt ID: | P85A_HUMAN |
| Description: | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) [Source:HGNC Symbol;Acc:8979] |
| Location: | chr5 q13.1 |
| Node attribute: | kinase; substrate |
| Phosphorylation site |
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|---|---|---|
| Y337 | NTEDQySLVED | INSR | HPRD |
| Y607 | NTEDQySLVED | InsR | RegPhos; SysPTM |
| Y310 | KTRDQyLMWLT | INSR | HPRD |
| Y688 | EPYNLySSLKE | phosphoELM; RegPhos | |
| S83 | GRKKIsPPTPK | PhosphoSitePlus | |
| S608 | TEDQYsLVEDD | PhosphoSitePlus; HPRD; phosphoELM; RegPhos | |
| Y528 | RIMHNyDKLKS | IncA; DUF1338 | PhosphoSitePlus |
| Y580 | KTRDQyLMWLT | INSR | HPRD; phosphoELM; RegPhos |
| Y688 | EPYNLySSLKE | LCK | HPRD; RegPhos |
| Y12 | QYRALyDYKKE | SH3_2 | PhosphoSitePlus |
| T490 | EAFNEtIKIFE | IncA; DUF1338 | PhosphoSitePlus |
| Y167 | EYDRLyEEYTR | HPRD | |
| Y368 | KMHGDyTLTLR | SH2 | PhosphoSitePlus |
| T369 | MHGDYtLTLRK | SH2 | PhosphoSitePlus |
| Y197 | EYDRLyEEYTR | HPRD | |
| Y607 | NTEDQySLVED | DUF1338 | PhosphoSitePlus; SysPTM |
| Y452 | KKLHEyNTQFQ | HPRD; phosphoELM | |
| Y68 | KMHGDyTLTLR | HPRD | |
| Y368 | KMHGDyTLTLR | InsR | RegPhos |
| Y59 | GWLNGyNETTG | SH3_2 | PhosphoSitePlus |
| S328 | TWNVGsSNRNK | HPRD | |
| Y467 | EYDRLyEEYTR | IncA; DUF1338 | PhosphoSitePlus |
| Y76 | GTYVEyIGRKK | SH3_2 | PhosphoSitePlus |
| Y418 | EPYNLySSLKE | LCK | HPRD |
| Y73 | DFPGTyVEYIG | SH3_2 | PhosphoSitePlus |
| T603 | LGNENtEDQYS | DUF1338 | PhosphoSitePlus |
| Y426 | DVKLLyPVSKY | IncA | PhosphoSitePlus |
| Y98 | KMHGDyTLTLR | HPRD | |
| T454 | LHEYNtQFQEK | IncA; DUF1338 | PhosphoSitePlus |
| Y679 | KTATGyGFAEP | SH2 | PhosphoSitePlus |
| Y657 | SKQGCyACSVV | SH2 | PhosphoSitePlus |
| Y556 | KQAAEyREIDK | IncA; DUF1338 | PhosphoSitePlus |
| S329 | WNVGSsNRNKA | HPRD | |
| Y307 | NTEDQySLVED | INSR | HPRD |
| Y580 | KTRDQyLMWLT | DUF1338 | PhosphoSitePlus |
| S359 | WNVGSsNRNKA | HPRD | |
| Y98 | KMHGDyTLTLR | INSR | HPRD |
| T576 | IQLRKtRDQYL | DUF1338 | PhosphoSitePlus |
| Y280 | KTRDQyLMWLT | INSR | HPRD |
| Y388 | EPYNLySSLKE | LCK | HPRD |
| Y152 | KKLHEyNTQFQ | HPRD | |
| S265 | NARVLsEIFSP | RhoGAP | PhosphoSitePlus |
| S629 | WNVGSsNRNKA | HPRD | |
| Y286 | KQAAEyREIDK | HPRD | |
| Y203 | IPAAVySEMIS | RhoGAP | PhosphoSitePlus |
| Y607 | NTEDQySLVED | SRC | phosphoELM; SysPTM |
| Y368 | KMHGDyTLTLR | HPRD; RegPhos | |
| S338 | TEDQYsLVEDD | HPRD | |
| Y556 | KQAAEyREIDK | HPRD; phosphoELM | |
| Y508 | RYSKEyIEKFK | IncA; DUF1338 | PhosphoSitePlus |
| Y580 | KTRDQyLMWLT | InsR | RegPhos |
| S147 | KGLECsTLYRT | RhoGAP | PhosphoSitePlus |
| Y607 | NTEDQySLVED | phosphoELM; RegPhos; SysPTM | |
| S628 | TWNVGsSNRNK | HPRD | |
| T623 | HHDEKtWNVGS | phosphoELM; RegPhos | |
| Y607 | NTEDQySLVED | INSR | HPRD; phosphoELM; RegPhos; SysPTM |
| Y368 | KMHGDyTLTLR | INSR | HPRD; phosphoELM; RegPhos |
| T152 | STLYRtQSSSN | RhoGAP | PhosphoSitePlus |
| S608 | TEDQYsLVEDD | PIK3CA | phosphoELM; RegPhos |
| T471 | LYEEYtRTSQE | IncA; DUF1338 | PhosphoSitePlus |
| Y256 | KQAAEyREIDK | HPRD | |
| Y452 | KKLHEyNTQFQ | IncA; DUF1338 | PhosphoSitePlus |
| Y470 | RLYEEyTRTSQ | IncA; DUF1338 | PhosphoSitePlus |
| Y580 | KTRDQyLMWLT | phosphoELM | |
| Y504 | QTQERySKEYI | IncA; DUF1338 | PhosphoSitePlus |
| Y688 | EPYNLySSLKE | SH2 | PhosphoSitePlus |
| Y467 | EYDRLyEEYTR | HPRD; phosphoELM; RegPhos | |
| Y68 | KMHGDyTLTLR | INSR | HPRD |
| S358 | TWNVGsSNRNK | HPRD | |
| S308 | TEDQYsLVEDD | HPRD | |
| Y182 | KKLHEyNTQFQ | HPRD | |
| T148 | GLECStLYRTQ | RhoGAP | PhosphoSitePlus |
| S154 | LYRTQsSSNLA | RhoGAP | PhosphoSitePlus |
| Y607 | NTEDQySLVED | Src | RegPhos; SysPTM |
| Y463 | EKSREyDRLYE | IncA; DUF1338 | PhosphoSitePlus |
| Dephosphorylation site |
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|---|---|---|
| S308 | ENTEDQYsLVEDDED | PPM1A | HPRD |
| S338 | ENTEDQYsLVEDDED | PPM1A | HPRD |
| S608 | ENTEDQYsLVEDDED | PPM1A | HPRD |
| Mutation site |
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|---|---|---|---|
| ENSP00000274335 | R358* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000429277 | R358* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000429277 | G71* | COSMIC | Lung Cancer | |
| ENSP00000274335 | N564K | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000429277 | N527K | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000428056 | N527K | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000274335 | R649Q | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000429277 | D560Y | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000274335 | R348* | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000428056 | D13V | BIOMART | Breast Cancer | 21930507, 21930502 |
| ENSP00000428056 | Y334* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000428056 | R348* | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000274335 | L570P | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000429277 | D464H | COSMIC | Central Nervous System Neoplasms | 18772396 |
| ENSP00000428056 | D560Y | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000274335 | R642* | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000428056 | E666K | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000274335 | E666K | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000429277 | L570P | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000429277 | K567E | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000274335 | D13V | BIOMART | Breast Cancer | 21930507, 21930502 |
| ENSP00000428056 | R543I | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000429277 | I290V | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000274335 | R301* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000428056 | R642* | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000428056 | R639* | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000428056 | A682V | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000274335 | D548G | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000428056 | G376R | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000428056 | R574T | COSMIC | Other Cancer | 21533174 |
| ENSP00000274335 | R386G | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000428056 | R358* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000274335 | G376R | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000274335 | D560Y | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000274335 | K459E | COSMIC | Central Nervous System Neoplasms | 18772396 |
| ENSP00000428056 | K459E | COSMIC | Central Nervous System Neoplasms | 18772396 |
| ENSP00000274335 | N260S | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000429277 | A634P | COSMIC | Breast Cancer | 20668451 |
| ENSP00000428056 | L570P | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000274335 | A634P | COSMIC | Breast Cancer | 20668451 |
| ENSP00000429277 | N260S | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000429277 | R348* | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000274335 | Y334* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000274335 | K567E | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000428056 | N260S | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000429277 | D548G | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000428056 | R461* | COSMIC | Intestines Cancer | |
| ENSP00000274335 | R162* | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000274335 | N285H | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000274335 | R461* | COSMIC | Intestines Cancer | |
| ENSP00000429277 | D13V | BIOMART | Breast Cancer | 21930507, 21930502 |
| ENSP00000428056 | R649Q | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000274335 | T473S | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000429277 | N285H | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000429277 | R386G | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000428056 | N285H | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000274335 | R574T | COSMIC | Other Cancer | 21533174 |
| ENSP00000429277 | Y334* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000274335 | D464H | COSMIC | Central Nervous System Neoplasms | 18772396 |
| ENSP00000429277 | N564K | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000429277 | E666K | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000429277 | G376R | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000429277 | K459E | COSMIC | Central Nervous System Neoplasms | 18772396 |
| ENSP00000429277 | L449S | COSMIC | Breast Cancer | 19962665 |
| ENSP00000429277 | R642* | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000274335 | I290V | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000274335 | L449S | COSMIC | Breast Cancer | 19962665 |
| ENSP00000428056 | A634P | COSMIC | Breast Cancer | 20668451 |
| ENSP00000274335 | K448fs*32 | COSMIC | Lymphoma | |
| ENSP00000429277 | R301* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000274335 | N527K | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000429277 | E495* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000429277 | R543I | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000428056 | R162* | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000428056 | T473S | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000274335 | G71* | COSMIC | Lung Cancer | |
| ENSP00000274335 | C498* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000429277 | R574T | COSMIC | Other Cancer | 21533174 |
| ENSP00000379855 | D13V | BIOMART | Breast Cancer | 21930507, 21930502 |
| ENSP00000428056 | K448fs*32 | COSMIC | Lymphoma | |
| ENSP00000429277 | R649Q | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000274335 | E495* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000429277 | K448fs*32 | COSMIC | Lymphoma | |
| ENSP00000428056 | C498* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000428056 | R301* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000429277 | T473S | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000429277 | A682V | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000274335 | A682V | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000428056 | G71* | COSMIC | Lung Cancer | |
| ENSP00000429277 | R162* | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000428056 | D464H | COSMIC | Central Nervous System Neoplasms | 18772396 |
| ENSP00000429277 | R639* | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000428056 | N564K | COSMIC | Central Nervous System Neoplasms | 18772890 |
| ENSP00000428056 | D548G | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000429277 | C498* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000274335 | R639* | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000428056 | I290V | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000428056 | R386G | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000274335 | R543I | COSMIC | Intestines Cancer | 19962665 |
| ENSP00000428056 | E495* | COSMIC | Uterine Cancer | 21478295 |
| ENSP00000428056 | L449S | COSMIC | Breast Cancer | 19962665 |
| ENSP00000428056 | K567E | COSMIC | Uterine Cancer | 21984976 |
| ENSP00000429277 | R461* | COSMIC | Intestines Cancer | |
| Differential expressed protein |
| P85A_HUMAN is not differential expressed protein. |
| Hyperphosphorylation site |
| P85A_HUMAN do not have hyperphosphorylation site. |
| Direct Interaction Pair |
| Source | Target | Relationship | Resource |
|---|---|---|---|
| ZAGL2_HUMAN | P85A_HUMAN | kinase -> substrate | RegPhos |
| LCK_HUMAN | P85A_HUMAN | kinase -> substrate | HPRD; RegPhos; NetPath |
| KIT_HUMAN | P85A_HUMAN | kinase -> substrate | NetPath |
| FYN_HUMAN | P85A_HUMAN | kinase -> substrate | NetPath |
| IL2RG_HUMAN | P85A_HUMAN | kinase -> substrate | NetPath |
| INSR_HUMAN | P85A_HUMAN | kinase -> substrate | RegPhos |
| PK3CA_HUMAN | P85A_HUMAN | kinase -> substrate | RegPhos |
| P85A_HUMAN | AKT1_HUMAN | kinase -> substrate | NetPath |
| PPM1A_HUMAN | P85A_HUMAN | phosphatase -> substrate | HPRD |
| Function Annotation |
| KEGG Pathway |
| KEGG ID | Pathway |
|---|---|
| hsa04062 | Chemokine signaling pathway |
| hsa04960 | Aldosterone-regulated sodium reabsorption |
| hsa05222 | Small cell lung cancer |
| hsa04722 | Neurotrophin signaling pathway |
| hsa04662 | B cell receptor signaling pathway |
| hsa05210 | Colorectal cancer |
| hsa05203 | Viral carcinogenesis |
| hsa04664 | Fc epsilon RI signaling pathway |
| hsa04070 | Phosphatidylinositol signaling system |
| hsa05162 | Measles |
| hsa04660 | T cell receptor signaling pathway |
| hsa05220 | Chronic myeloid leukemia |
| hsa04910 | Insulin signaling pathway |
| hsa04620 | Toll-like receptor signaling pathway |
| hsa04725 | Cholinergic synapse |
| hsa05218 | Melanoma |
| hsa05100 | Bacterial invasion of epithelial cells |
| hsa05146 | Amoebiasis |
| hsa05214 | Glioma |
| hsa04370 | VEGF signaling pathway |
| hsa04210 | Apoptosis |
| hsa04930 | Type II diabetes mellitus |
| hsa04380 | Osteoclast differentiation |
| hsa04510 | Focal adhesion |
| hsa04150 | mTOR signaling pathway |
| hsa05221 | Acute myeloid leukemia |
| hsa05142 | Chagas disease (American trypanosomiasis) |
| hsa05145 | Toxoplasmosis |
| hsa05212 | Pancreatic cancer |
| hsa04670 | Leukocyte transendothelial migration |
| hsa05166 | HTLV-I infection |
| hsa05200 | Pathways in cancer |
| hsa05160 | Hepatitis C |
| hsa05223 | Non-small cell lung cancer |
| hsa04630 | Jak-STAT signaling pathway |
| hsa04012 | ErbB signaling pathway |
| hsa04973 | Carbohydrate digestion and absorption |
| hsa05213 | Endometrial cancer |
| hsa05215 | Prostate cancer |
| hsa05164 | Influenza A |
| hsa04914 | Progesterone-mediated oocyte maturation |
| hsa05211 | Renal cell carcinoma |
| hsa04650 | Natural killer cell mediated cytotoxicity |
| hsa04666 | Fc gamma R-mediated phagocytosis |
| hsa05169 | Epstein-Barr virus infection |
| hsa04810 | Regulation of actin cytoskeleton |
| Gene Ontology |
| GO ID | GO_Term | Evidence | Ontology |
|---|---|---|---|
| GO:0043560 | insulin receptor substrate binding | IEA | molecular_function |
| GO:0050900 | leukocyte migration | TAS | biological_process |
| GO:0060396 | growth hormone receptor signaling pathway | IDA | biological_process |
| GO:0005829 | cytosol | IEA | cellular_component |
| GO:0005737 | cytoplasm | IEA | cellular_component |
| GO:0005158 | insulin receptor binding | IPI | molecular_function |
| GO:0005515 | protein binding | IEA | molecular_function |
| GO:0030183 | B cell differentiation | IEA | biological_process |
| GO:0043551 | regulation of phosphatidylinositol 3-kinase activi | ISS | biological_process |
| GO:0007165 | signal transduction | IEA | biological_process |
| GO:0005886 | plasma membrane | TAS | cellular_component |
| GO:0007596 | blood coagulation | TAS | biological_process |
| GO:0005515 | protein binding | IPI | molecular_function |
| GO:0005829 | cytosol | TAS | cellular_component |
| GO:0045944 | positive regulation of transcription from RNA poly | IEA | biological_process |
| GO:0031295 | T cell costimulation | TAS | biological_process |
| GO:0006644 | phospholipid metabolic process | TAS | biological_process |
| GO:0030168 | platelet activation | TAS | biological_process |
| GO:0008286 | insulin receptor signaling pathway | IPI | biological_process |
| GO:0045671 | negative regulation of osteoclast differentiation | IEA | biological_process |
| GO:0005525 | GTP binding | IEA | molecular_function |
| GO:0034644 | cellular response to UV | IEA | biological_process |
| GO:0005622 | intracellular | IEA | cellular_component |
| GO:0046326 | positive regulation of glucose import | ISS | biological_process |
| GO:0003924 | GTPase activity | IEA | molecular_function |
| GO:0051531 | NFAT protein import into nucleus | IEA | biological_process |
| GO:0019903 | protein phosphatase binding | IPI | molecular_function |
| GO:0008543 | fibroblast growth factor receptor signaling pathwa | TAS | biological_process |
| GO:0005943 | 1-phosphatidylinositol-4-phosphate 3-kinase, class | ISS | cellular_component |
| GO:0048009 | insulin-like growth factor receptor signaling path | IPI | biological_process |
| GO:0005942 | phosphatidylinositol 3-kinase complex | IEA | cellular_component |
| GO:0035014 | phosphatidylinositol 3-kinase regulator activity | IEA | molecular_function |
| GO:0007173 | epidermal growth factor receptor signaling pathway | TAS | biological_process |
| GO:0043125 | ErbB-3 class receptor binding | IDA | molecular_function |
| GO:0050852 | T cell receptor signaling pathway | TAS | biological_process |
| GO:0048011 | nerve growth factor receptor signaling pathway | TAS | biological_process |
| GO:0005159 | insulin-like growth factor receptor binding | IPI | molecular_function |
| GO:0019048 | virus-host interaction | IEA | biological_process |
| GO:0030335 | positive regulation of cell migration | IEA | biological_process |
| GO:0016020 | membrane | IEA | cellular_component |
| GO:0043065 | positive regulation of apoptotic process | IEA | biological_process |
| GO:0005545 | 1-phosphatidylinositol binding | NAS | molecular_function |
| GO:0001953 | negative regulation of cell-matrix adhesion | IEA | biological_process |
| GO:0046854 | phosphatidylinositol phosphorylation | ISS | biological_process |
| GO:0090004 | positive regulation of establishment of protein lo | ISS | biological_process |
| GO:0043559 | insulin binding | IDA | molecular_function |
| GO:0048015 | phosphatidylinositol-mediated signaling | TAS | biological_process |
| GO:0005168 | neurotrophin TRKA receptor binding | IPI | molecular_function |
| GO:0006661 | phosphatidylinositol biosynthetic process | TAS | biological_process |
| GO:0005068 | transmembrane receptor protein tyrosine kinase ada | ISS | molecular_function |
| GO:0043548 | phosphatidylinositol 3-kinase binding | ISS | molecular_function |
| GO:0006468 | protein phosphorylation | IEA | biological_process |
| GO:0014065 | phosphatidylinositol 3-kinase cascade | IDA | biological_process |
| GO:0043066 | negative regulation of apoptotic process | IEA | biological_process |
| GO:0044281 | small molecule metabolic process | TAS | biological_process |